REQUEST A DEMO
Total
USD $0.00
Search more companies

Macrogen Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Macrogen Inc. Profile Updated: July 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Macrogen Inc. is engaged in research and development of basic tools for genome medicine including genetic information analysis to functional genomics. The company invented 'Super Alcohol Bacteria' and a congenital-hereditary-disease diagnosing kit. Macrogen Inc. also commercialized genetically engineered mice production, cloning and xenotransplant technology. The company operates in five business divisions: Sequencing is engaged in research projects such as Korea Genome BAC Clone Map and Zymomonas mobilis Genome Project; Oligo provides Oligo Synthesis services such as MOPCTM purification method; Biochip provides DNA Chip total solution including MacArray™ Express Oligochip, MacArray™ Karyo and MacProbe™; Mouse is engaged in functional genomics research providing transgenic/knockout mice; and Bioinformatics is engaged in providing BT & IT human resources services including database construction, Genome Research, and Bioinformatics comprehensive analysis system consulting services. The company is based in Seoul, South Korea with affiliated companies in markets including USA, Japan, and Europe. Macrogen Inc. was incorporated in 1997.

Headquarters
10F Word Merdian Venture Center, 60-24 Gasan-Dong, Geumcheon-Gu
Seoul; Seoul; Postal Code: 153-801

Contact Details: Purchase the Macrogen Inc. report to view the information.

Website: http://www.macrogen.com

Basic Information
Total Employees:
Purchase the Macrogen Inc. report to view the information.
Outstanding Shares:
Purchase the Macrogen Inc. report to view the information.
Registered Capital:
Purchase the Macrogen Inc. report to view the information.
Financial Auditors:
Purchase the Macrogen Inc. report to view the information.
Incorporation Date:
June 05, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
8.74%
Purchase this report to view the information.
0.87%
Purchase this report to view the information.
0.77%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
0.15%
Subsidiaries
㈜마크로젠
Company Performance
Financial values in the chart are available after Macrogen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-4.19%
Total operating revenue
-9.07%
Operating profit (EBIT)
-87.86%
EBITDA
N/A
Net Profit (Loss) for the Period
23.88%
Total assets
-7.96%
Total equity
-11.05%
Operating Profit Margin (ROS)
-5.43%
Net Profit Margin
3.26%
Return on Equity (ROE)
1.75%
Debt to Equity Ratio
2.78%
Quick Ratio
-0.32%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?